AccuGenomics is pleased to announce that it has received notification of a grant award from a USAF-SBIR grant submission for topic AF211-DCSO1 and project F2D-3025. This award is from a grant submission entitled “Ensuring Accuracy of NGS COVID-19 Variants and Other Pathogen Testing with SNAQ™-SEQ Internal Standards”, and is valued at $750,000. This project will result in a highly accurate measure of viral load as well as provide QC metrics for complexity capture of the sample and workflow. The award of these funds will support the creation of software that integrates the AccuGenomics SNAQ™-SEQ analysis into the USAF bioinformatic pipeline, and will create novel SNAQ™-SEQ internal standards for Influenza.
AccuGenomics manufactures innovative multiplexed spike-in QC standards (SNAQ™-SEQ) that enable a host of highly sensitive next-generation sequencing applications. SNAQ™-SEQ internal standards improve the accuracy and performance of NGS-based assays. Our solution of internal quality control standards from our SNAQ™-SEQ technology will improve sensitivity and accuracy for NGS COVID-19 variants and other pathogen testing of infectious diseases. Specifically, our technology can quantify the viral load of COVID-19 and enable variant detection down to 0.1%. Our corporate headquarters include over 5000 sf of development and manufacturing suites and are located in Wilmington, NC.
AFRL and AFWERX have partnered to streamline the Small Business Innovation Research process in an attempt to speed up the experience, broaden the pool of potential applicants and decrease bureaucratic overhead. Beginning in SBIR 18.2, and now in 20.R, the Air Force has begun offering Special SBIR topics (such as AF211-DCSO1) that are faster, leaner and open to a broader range of innovations. AccuGenomics has been inducted into this group, and is pleased to be able to support the critical work of the USAF.
Interested parties are invited to contact us for additional information or partnership discussions.